We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $625M Turnover 41.45%
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$102M
AUM Growth
-$13.3M
Cap. Flow
-$16.5M
Cap. Flow %
-16.18%
Top 10 Hldgs %
53.41%
Holding
79
New
4
Increased
12
Reduced
30
Closed
9
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.4 years

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$2.23M
2
TRMB icon
Trimble
TRMB
+$1.52M
3
MTZ icon
MasTec
MTZ
+$1.44M
4
MRC icon
MRC Global
MRC
+$1.41M
5
FXI icon
iShares China Large-Cap ETF
FXI
+$1.29M

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.29%
2 Technology 16.25%
3 Industrials 7.77%
4 Energy 7.68%
5 Healthcare 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TRMB icon
76
Trimble
TRMB
$14.2B
– –
-39,000
Closed -$1.52M –
AGN
77
DELISTED
Allergan Inc
AGN
– –
-17,965
Closed -$2.23M –

Similar funds

Bellecapital's Q2 2014 Portfolio in Review

As of Q2 2014, Bellecapital held 79 positions worth $102M, down 12% from $115M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Bellecapital withdrew a net $16.5M in Q2 2014, closing 9 positions and reducing 30 holdings. Its most notable exit was Allergan Inc, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 51% a quarter earlier, followed by Technology and Industrials.

Against the trend, Bellecapital opened a new position in PIMCO Enhanced Short Maturity Active Exchange-Traded Fund worth $608K.

  • Bellecapital's largest Q2 2014 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 6,000 shares worth $608K.
  • Bellecapital added most to Alphabet (Google) Class C in Q2 2014, an estimated $501K increase.
  • Bellecapital's biggest Q2 2014 reduction was MasTec, cutting an estimated $1.44M.
  • Bellecapital fully exited Allergan Inc in Q2 2014, selling an estimated $2.23M.
  • Bellecapital's ten largest holdings make up 53% of its $102M portfolio in Q2 2014.
  • Bellecapital opened 4 new positions and closed 9 in Q2 2014.
  • Bellecapital's portfolio value fell 12% quarter-over-quarter to $102M.

Based on Bellecapital's 13F filing for Q2 2014, filed 23 Jul 2014.